Dannex Ayrton Starwin Limited (DASL.gh)

Dannex Ayrton Starwin Plc (DAS PLC) – Accra, Ghana

Industry: Pharmaceutical Sector

Core Business Activities: Dannex Ayrton Starwin Plc (DAS PLC) is a leading Ghanaian pharmaceutical company primarily engaged in the manufacturing, importing, and selling of a diverse range of pharmaceutical products. Its core portfolio includes Syrups, Tablets, Creams/Ointments, Suspensions, Powders, Capsules, and Emulsions. The company focuses on its domestic market, with sales disaggregated across Accra, Kumasi, Tamale, and Takoradi, demonstrating a strong national footprint in healthcare delivery.

Market Position: DAS PLC is a significant player in the Ghanaian pharmaceutical industry, providing essential healthcare products. The company aims to be the brand of choice in its markets with a strong footprint in Africa and beyond. Its commitment to compliance, exemplified by the pursuit of WHO CGMP standards, positions it for sustained quality and competitive strength.

Number of Employees: The average number of employees at the end of the period was 559 (down from 617 in 2023).

Financial Highlights: The company demonstrated a strong financial performance for the year ended 31 December 2024, showing significant growth despite economic challenges. Total Revenue reached GHS 173,108,660, a notable increase from GHS 141,003,384 in 2023. Profit After Tax rose by 36.8% to GHS 10,407,411, compared to GHS 7,553,731 in the previous year. Total assets also improved, increasing from GHS 78,217,554 in 2023 to GHS 100,807,643 in 2024. These figures are based on the Dannex Ayrton Starwin Plc Annual Report and Financial Statements for the Year Ended 31 December 2024.

Vision Statement: “To be the brand of choice in our chosen markets with a strong footprint in Africa and beyond.”

Mission Statement: “Caring for life with brands, products and services, which significantly reduce disease burden and promote good health and vitality.”

Key Figures (Year Ended 31 December 2024):

• Revenue: GHS 173,108,660
• Gross Profit: GHS 94,785,577
• Profit Before Tax: GHS 14,423,355
• Profit After Tax: GHS 10,407,411
• Total Assets: GHS 100,807,643
• Total Shareholders: 8,549

Sustainability Focus (Environmental, Social, and Governance – ESG)

DAS PLC is committed to being a good corporate citizen, integrating Corporate Social Responsibility (CSR) and strong Corporate Governance into its operations. The company has established an ad-hoc Environmental, Social, and Governance (ESG) Committee to implement ESG Reporting in line with Ghana Stock Exchange requirements.

Social Impact: The company actively supports the community through product donations, contributing a total of GHS 54,076 to various institutions in 2024, including health and education-focused organisations. A notable initiative was the partnership with an NGO to distribute free Ferrodex Iron tablets to pregnant women to combat anaemia. DAS PLC also maintains an internship programme for students from major tertiary institutions, fostering skill development.

Corporate Governance: The company maintains a robust framework with a Board Charter, a documented Code of Business Policies, and mandatory Board Committees (Audit, Risk, Nominating, and Remuneration) to ensure transparency, accountability, and ethical conduct. The Board comprises three Executive Directors (including the Chairman) and five Non-Executive Directors, ensuring diverse oversight. The company complies with all legal and regulatory requirements and has established a comprehensive Health, Safety, and Environment system to safeguard employees and the environment.

Environmental Responsibility: The company is committed to conducting business with respect for environmental requirements, actively working to avoid activities that negatively impact the environment.